Monday, March 06, 2017

Ablordeppey continues $1.4M in NIH-funded research on antipsychotic drugs

Seth Y. Ablordeppey, a professor of Medicinal Chemistry and the Director of the Pharmaceutical Sciences Division of the College of Pharmacy and Pharmaceutical Sciences at Florida Agricultural and Mechanical University (FAMU), continuing a $1,411,289 research project funded by the National Institutes of Health (NIH).

NIH awarded Ablordeppey four years of funding for a project entitled “A New Approach for the Development of Novel Antipsychotic Drugs.” The organization released $337,755 to him in the fiscal year ending (FYE) 2016 and $300,180 for FYE 2017.

The project focuses on developing better drugs to treat schizophrenia.

“According to the National Institute of Mental Health, approximately 2.4 million American adults, or about 1.1 percent of the population age 18 and older in a given year, are affected by schizophrenia,” says the project description. “Of this number, it is estimated that up to a third of patients are unresponsive to current treatment options. An even more heart-breaking statistics is the fact that between 9-13% of patients eventually takes their own lives because of the illness.”

“This calls for an urgent effort to identify new agents in the pharmacotherapy of schizophrenia,” the statement continues. “The long term goal of this proposal therefore, is to develop new agents that have improved therapeutic profiles over the current antipsychotics in use.”

No comments: